DOPA-responsive dystonia

Show Summary Details

Quick Reference


an autosomal dominant progressive dystonia that starts in childhood and results from deficiency of tetrahydrobiopterin, the cofactor for tyrosine hydroxylase. Caused by mutations in guanosine triphosphate cyclohydrolase, it responds dramatically to treatment with DOPA or dopamine.


Subjects: Chemistry.

Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.